Clinical Trial: A Study of Pharmacokinetics and Safety of LY3537031 in Participants With Normal Renal Function and Participants With Renal Impairment

U.S., Sept. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07165015) titled 'A Study of Pharmacokinetics and Safety of LY3537031 in Participants With Normal Renal Function and Participants With Renal Impairment' on Sept. 03.

Brief Summary: The purpose of this study is to assess the amount of LY3537031 that reaches the bloodstream and the time it takes for the body to get rid of it when given to participants with renal (kidney) impairment and to healthy participants.

Study Start Date: Sept., 2025

Study Type: INTERVENTIONAL

Condition: Renal Impairment Healthy Renal Insufficiency End Stage Renal Disease (ESRD)

Intervention: DRUG: LY3537031

Administered SC

Recruitment Status: NOT_YET_RECRUITING

Sponsor...